Lunch Break & Networking

The afternoon session will cover:

• Understanding the biological principles of ADCs and selecting the most appropriate target and antibody format
• Analysing the key choices, trade-offs, and design considerations across the ADC chemistry toolbox
• Evaluating preclinical in vivo efficacy data and the critical factors that inform successful ADC development and translation to the clinic